Celcuity Inc.
Celcuity Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 145 | 166 | 74 | 46 | 16 | 23 | 13 | 30 | 31 | 31 | 26 | 32 | |||||
Short Term Investments | 242 | 276 | 381 | 122 | 189 | 213 | 251 | 253 | 146 | 150 | 108 | 114 | |||||
Deposits Assets Current | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Assets Current | |||||||||||||||||
Assets Current | 409 | 466 | 475 | 183 | 218 | 245 | 272 | 292 | 188 | 191 | 142 | 153 | |||||
Deferred Costs Current | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Other Prepaid Expense Current | 15 | 19 | - | - | - | 7 | - | - | - | - | - | - | |||||
Other Assets Current | 6 | 5 | 21 | 15 | 12 | 3 | 8 | 9 | 10 | 10 | 8 | 6 | |||||
Property Plant And Equipment Net | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets Noncurrent | 1 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Assets | 410 | 467 | 476 | 184 | 218 | 245 | 273 | 293 | 188 | 191 | 142 | 154 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable Current | 10 | 6 | 11 | 11 | 10 | 9 | 9 | 6 | 5 | 5 | 6 | 3 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 33 | 44 | 39 | 40 | 33 | 32 | 26 | 20 | 17 | 14 | 13 | 7 | |||||
Other Liabilities Current | 14 | 21 | - | - | - | 5 | - | - | - | - | - | - | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accrued Liabilities Current | - | - | 27 | 29 | 23 | 22 | 17 | 13 | 11 | 9 | 7 | 4 | |||||
Operating Lease Liability Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Value | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Convertible Debt Noncurrent | 196 | 195 | 195 | - | - | - | - | - | - | - | - | - | |||||
Long Term Notes Payable | 128 | 127 | 125 | 99 | 99 | 98 | 97 | 96 | 38 | 37 | 37 | 36 | |||||
Liabilities | 357 | 366 | 359 | 139 | 131 | 130 | 123 | 116 | 54 | 51 | 49 | 43 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Additional Paid In Capital | 555 | 549 | 515 | 398 | 395 | 387 | 385 | 382 | 315 | 300 | 234 | 233 | |||||
Stockholders Equity | 54 | 101 | 117 | 44 | 87 | 116 | 150 | 177 | 134 | 140 | 93 | 110 | |||||
Retained Earnings Accumulated Deficit | -502 | -449 | -398 | -354 | -309 | -272 | -235 | -205 | -182 | -160 | -141 | -123 | |||||
Liabilities And Stockholders Equity | 410 | 467 | 476 | 184 | 218 | 245 | 273 | 293 | 188 | 191 | 142 | 154 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Preferred Stock Shares Issued | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 95 | 95 | 95 | 95 | 95 | 95 | 65 | 65 | 65 | 65 | 65 | 65 | |||||
Common Stock Shares Issued | 48 | 48 | 43 | 39 | 38 | 37 | 37 | 37 | 31 | 26 | 22 | 22 | |||||
Shares Outstanding | 48 | 48 | 43 | 39 | 38 | 37 | 37 | 37 | 31 | 26 | 22 | 22 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -34.47% | -19.87% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 24.05% | 31.08% | 279.37% | 7.31% | -2.66% | 48.70% | 22.83% | 16.92% | 27.23% | 6.66% | 19.92% | -22.87% |
| 2024 | -17.06% | -2.32% | 0.29% | -7.78% | -7.90% | -8.57% | -6.80% | -3.47% | -15.31% | 6.82% | 3.26% | 14.74% |
| 2023 | 15.97% | 3.24% | 9.19% | -0.40% | -7.58% | -0.10% | 35.72% | 26.17% | 42.06% | -5.07% | -7.71% | -17.24% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 12.31 | 10.55 | 12.26 | 4.58 | 6.61 | 7.71 | 10.36 | 14.95 | 11.23 | 13.43 | 11.15 | 21.58 | |||||
| Quick Ratio | 12.31 | 10.55 | 12.26 | 4.58 | 6.61 | 7.71 | 10.36 | 14.95 | 11.23 | 13.43 | 11.15 | 21.58 | |||||
| Working Capital | 375.72M | 421.51M | 436.71M | 143.16M | 184.68M | 212.85M | 246.13M | 272.40M | 170.83M | 176.40M | 129.00M | 145.72M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 6.66 | 3.64 | 3.07 | 3.14 | 1.52 | 1.12 | 0.82 | 0.66 | 0.41 | 0.37 | 0.53 | 0.39 | |||||
| Interest Coverage TTM | -9.31 | -10.04 | -11.18 | -11.27 | -10.52 | -11.02 | -11.49 | -13.28 | -13.89 | -12.43 | -12.62 | -13.22 | |||||
| Debt Ratio | 0.87 | 0.78 | 0.75 | 0.76 | 0.60 | 0.53 | 0.45 | 0.40 | 0.29 | 0.27 | 0.35 | 0.28 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -3.54 | -3.79 | -3.42 | -3.41 | -2.95 | -2.83 | -2.20 | -2.15 | -2.19 | -2.69 | -2.56 | -2.23 | |||||
| Free Cash Flow Per Share TTM | -3.18 | -3.28 | -3.04 | -2.76 | -2.38 | -2.12 | -1.74 | -1.73 | -1.73 | -2.28 | -2.03 | -1.89 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | 51.68% | 58.39% | 73.16% | 80.06% | 73.12% | 75.26% | 66.29% | 68.54% | 65.53% | 57.99% | 59.00% | 59.74% | |||||
| EPS Growth (1Y) | 19.91% | 33.63% | 55.70% | 58.54% | 35.16% | 5.20% | -14.05% | -3.74% | 6.77% | 2.87% | 7.39% | 8.62% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -32.23 | -26.34 | -14.45 | -3.92 | -3.42 | -4.62 | -6.79 | -7.62 | -9.88 | -5.41 | -3.58 | -4.92 | |||||
| P/B TTM | 116.14 | 46.38 | 20.10 | 13.14 | 5.02 | 4.47 | 4.26 | 3.56 | 5.43 | 2.47 | 2.18 | 2.19 | |||||
| Market Cap | 6.22B | 4.66B | 2.35B | 582.91M | 435.26M | 516.39M | 638.04M | 629.72M | 726.02M | 345.01M | 202.16M | 241.09M | |||||
| Enterprise Value | 6.39B | 4.82B | 2.60B | 635.83M | 517.31M | 591.60M | 722.36M | 695.45M | 732.37M | 351.38M | 212.90M | 244.84M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -172.93M | -153.53M | -144.89M | -120.59M | -102.47M | -83.72M | -74.47M | -66.66M | -58.19M | -53.91M | -44.93M | -41.45M | |||||
| Net Debt | 178.24M | 156.15M | 246.00M | 52.92M | 82.05M | 75.21M | 84.32M | 65.73M | 6.35M | 6.37M | 10.75M | 3.75M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Celcuity Inc. (CELC) — SEC Financial Statements & Analysis
Celcuity Inc. (CELC) is a services-medical laboratories company, incorporated in DE. Celcuity Inc. trades on CELC: Nasdaq as: CELC. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Celcuity Inc. reported a Debt-to-Equity ratio of 6.66x, a Price-to-Book (P/B) ratio of 116.14 (TTM), at a market cap of $6.22B. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 6.66x
- P/B TTM
- 116.14
- Market Cap
- $6.22B
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Celcuity Inc. in?
Celcuity Inc. (CELC) operates in the Services-Medical Laboratories industry.
What is CELC's market cap?
Celcuity Inc. (CELC) has a market capitalization of $6.22B as of 2026-03-31.
What exchange does CELC trade on?
Celcuity Inc. (CELC) trades on the CELC: Nasdaq.
Where is Celcuity Inc. incorporated?
Celcuity Inc. is incorporated in DE.